BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4678126)

  • 1. [Overadditive synergism of combinations of cyclophosphamide with thymidine, adenosine or uridine in transplantation tumors].
    Osswald H
    Arzneimittelforschung; 1972 Jul; 22(7):1184-8. PubMed ID: 4678126
    [No Abstract]   [Full Text] [Related]  

  • 2. Uridine enhances the chemotherapeutic action of the 4'-demethylepipodophyllotoxin-thenylidene-glucoside (VM 26)-cyclophosphamide combination on i.m. implanted Ehrlich carcinoma.
    Osswald H
    Arzneimittelforschung; 1978; 28(3):387-8. PubMed ID: 580745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergistic effect of the combination of thymidine and cyclophosphamide on Ehrlich ascites tumor].
    Osswald H
    Z Krebsforsch; 1970; 74(4):376-82. PubMed ID: 4253311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the combined use of pyrogenal and cyclophosphane on experimental tumors].
    Kolosov AI; Krupkin RG
    Vopr Onkol; 1977; 23(10):90-2. PubMed ID: 595532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
    Frankfurt OS
    Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of the chemotherapeutic effect of vinblastine by thymidine].
    Osswald H
    Arzneimittelforschung; 1972 Aug; 22(8):1421. PubMed ID: 4678405
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the combined effects of 5-bromouracil-2-desoxyriboside and x-rays on animal tumors].
    Maass H; Grote KH
    Strahlentherapie; 1967 May; 133(1):102-7. PubMed ID: 5584666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
    Pukhal'skaia ECh; Platonova GN
    Biull Eksp Biol Med; 1971 Oct; 72(10):82-5. PubMed ID: 5126158
    [No Abstract]   [Full Text] [Related]  

  • 11. [The time dependent, electronically measured change in volume frequency distribution of Ehrlich ascites tumor cells after treatment with alkylating cytostatics in vivo].
    Gutsche W
    Arzneimittelforschung; 1971 Apr; 21(4):444-6. PubMed ID: 5108137
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of lysolecithin and analogs on mouse ascites tumors.
    Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O
    Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug responses of S-180 tumours in syngeneic and xenogeneic hosts.
    Chowdhury T; Lahiri T
    Indian J Exp Biol; 1986 Feb; 24(2):81-4. PubMed ID: 3089929
    [No Abstract]   [Full Text] [Related]  

  • 14. [The preparation of liposome entrapment of cyclophosphamide (CPL) in its reconstituted form and the properties and antitumor activities of reconstituted CPL].
    Gao XY; Gu XQ; Tao J
    Yao Xue Xue Bao; 1987 Aug; 22(8):612-8. PubMed ID: 3450167
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of the probit method for the evaluation of the effectiveness of rubomycin in the treatment of transplantable tumors in mice].
    Bazhanov VS
    Antibiotiki; 1971; 16(8):714-8. PubMed ID: 5171848
    [No Abstract]   [Full Text] [Related]  

  • 16. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM; Gale GR
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytostatic-testing with the particle counter TuR ZG 1].
    Gutsche W
    Arzneimittelforschung; 1968 Feb; 18(2):258-9. PubMed ID: 5695392
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of cytostatics on sialic acid level in Ehrlich mouse tumor].
    Tatsumi N
    Osaka City Med J; 1972; 18(1):101-8. PubMed ID: 4665970
    [No Abstract]   [Full Text] [Related]  

  • 20. Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
    Gale GR; Walker EM; Atkins LM; Smith AB; Meischen SJ
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):529-38. PubMed ID: 4824827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.